Yung-Tsu Cho

Dr. Yung-Tsu Cho

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YCYung-Tsu Cho
Yung-Tsu Cho
CYChe-Wen Yang
Che-Wen Yang
CCChia-Yu Chu
Chia-Yu Chu
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe multiorgan hypersensitivity reaction mostly caused by a limited number of eliciting drugs in patients with a genetic predisposition. Patients with DRESS syndrome present with characteristic but variable clinical and pathological features. Reactivation of human herpesviruses (HHV), especially HHV-6, is the hallmark of the disease. Anti-viral immune responses intertwined with drug hypersensitivity make the disease more complicated and protracted. In recent years, emerging studies have outlined the disease more clearly, though several important questions remain unresolved. In this review, we provide an overview of DRESS syndrome, including clinical presentations, histopathological features, pathomechanisms, and treatments.

1 March 2013 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
YCYi-Chun Chen
Yi-Chun Chen
CCChia-Ying Chang
Chia-Ying Chang
YCYung-Tsu Cho
Yung-Tsu Cho
HCHsien-Ching Chiu
Hsien-Ching Chiu
CCChia-Yu Chu
Chia-Yu Chu

1 September 2018 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
TCTom C. Chan
Tom C. Chan
RSRiana D. Sanyal
Riana D. Sanyal
APAna B. Pavel
Ana B. Pavel
JGJacob Glickman
Jacob Glickman
XZXiuzhong Zheng
Xiuzhong Zheng
EGEmma Guttman-Yassky
Emma Guttman-Yassky

1 March 2014 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
YCYung-Tsu Cho
Yung-Tsu Cho
JLJheng-Wei Lin
Jheng-Wei Lin
YCYi-Chun Chen
Yi-Chun Chen
CCChia-Ying Chang
Chia-Ying Chang
CHCheng-Hsiang Hsiao
Cheng-Hsiang Hsiao
CCChia-Yu Chu
Chia-Yu Chu

1 January 2024 in JAMA Dermatology
Verified
Journal Article
Closed access
PDF file
MBMarie-Charlotte Brüggen
Marie-Charlotte Brüggen
SWSarah Walsh
Sarah Walsh
MAM. Milad Ameri
M. Milad Ameri
NANatalie Anasiewicz
Natalie Anasiewicz
EMEmanual Maverakis
Emanual Maverakis
YCYung-Tsu Cho
Yung-Tsu Cho
Importance: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but potentially fatal drug hypersensitivity reaction. To our knowledge, there is no international consensus on its severity assessment and treatment.Objective: To reach an international, Delphi-based multinational expert consensus on the diagnostic workup, severity assessment, and treatment of patients with DRESS.Design, Setting, and Participants: The Delphi method was used to assess 100 statements related to baseline workup, evaluation of severity, acute phase, and postacute management of DRESS. Fifty-seven international experts in DRESS were invited, and 54 participated in the survey, which took place from July to September 2022.Main Outcomes/Measures: The degree of agreement was calculated with the RAND-UCLA Appropriateness Method. Consensus was defined as a statement with a median appropriateness value of 7 or higher (appropriate) and a disagreement index of lower than 1.Results: In the first Delphi round, consensus was reached on 82 statements. Thirteen statements were revised and assessed in a second round. A consensus was reached for 93 statements overall. The experts agreed on a set of basic diagnostic workup procedures as well as severity- and organ-specific further investigations. They reached a consensus on severity assessment (mild, moderate, and severe) based on the extent of liver, kidney, and blood involvement and the damage of other organs. The panel agreed on the main lines of DRESS management according to these severity grades. General recommendations were generated on the postacute phase follow-up of patients with DRESS and the allergological workup.Conclusions and Relevance: This Delphi exercise represents, to our knowledge, the first international expert consensus on diagnostic workup, severity assessment, and management of DRESS. This should support clinicians in the diagnosis and management of DRESS and constitute the basis for development of future guidelines.

1 January 2015 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
KTKatsuyoshi Takata
Katsuyoshi Takata
MHMin-Eui Hong
Min-Eui Hong
PSPanitta Sitthinamsuwan
Panitta Sitthinamsuwan
FLFlorence Loong
Florence Loong
STSoo-Yong Tan
Soo-Yong Tan
SCShih-Sung Chuang
Shih-Sung Chuang
Primary cutaneous, extranodal natural killer/T-cell lymphoma, nasal type (PC-ENKTL), is a rare Epstein-Barr virus (EBV)-associated neoplasm with poorly defined clinicopathologic features. We performed a multinational retrospective study of PC-ENKTL and CD56-positive EBV-negative peripheral T-cell lymphoma (PC-CD56+PTCL) in Asia in an attempt to elucidate their clinicopathologic features. Using immunohistochemistry for T-cell receptors (TCRs), in situ hybridization for EBV, and TCR gene rearrangement, we classified 60 tumors into 51 with PC-ENKTL (20 of NK-cell, 17 T-cell, and 14 indeterminate lineages) and 9 with PC-CD56+PTCL. Tumors of T-cell origin accounted for 46% of PC-ENKTLs with half of these cases being TCR-silent. As compared with T-lineage tumors, PC-ENKTLs of NK-cell lineage had more frequent involvement of regional lymph nodes and more frequently CD8-negative and CD56-positive. Cases of PC-ENKTL showed more frequent tumor necrosis, younger age, and a higher frequency of CD16 and CD30 expression than cases of PC-CD56+PTCL. CD56-positive T-lineage PC-ENKTL tumors (n=8) had more localized disease in the TNM (tumor-node-metastasis) staging and were more often of γδ T-cell origin compared with cases of PC-CD56+PTCL (n=9). PC-ENKTLs and PC-CD56+PTCLs were equally aggressive, with a 5-year overall survival rate of 25%. Tumor necrosis and CD16 expression may serve as useful surrogates for differentiating PC-ENKTL from PC-CD56+PTCL. A single lesion, an elevated lactate dehydrogenase level, and the presence of B symptoms were independent poor prognostic factors for PC-ENKTL in multivariate analysis. Further studies with more cases are warranted to delineate the clinicopathologic features and significance of EBV in these rare lymphomas.